Procter & Gamble Health reports Q4 sales at Rs. 277 Cr
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
Gross profit was Rs. 328.8 crore, up by 27.8% YoY with a gross margin expansion of 418 bps to 55.7%
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
EBITDA at Rs. 250 crore, up 47% YoY, with 35% EBITDA margin
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
The innovative ‘Street Safe’ Rapid Testing Kit should be provided to all vendors attending the Food Safety and Certification (FoSTaC) trainings to ensure that safe food is used by the street food vendors across the country
Laurus Labs receives EIR from USFDA for API facilities
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Subscribe To Our Newsletter & Stay Updated